Vancomycin-resistant Staphylococcus aureus medical therapy: Difference between revisions
Hardik Patel (talk | contribs) Created page with "__NOTOC__ {{Vancomycin-resistant Staphylococcus aureus}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to lear..." |
Hardik Patel (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
VISA and VRSA cannot be successfully treated with [[vancomycin]] because these organisms are no longer susceptibile to vancomycin. However, to date, all VISA and VRSA isolates have been susceptible to other Food and Drug Administration (FDA) approved drugs like [[trimethoprim]]/[[sulfamethoxazole]], [[clindamycin]], or | VISA and VRSA cannot be successfully treated with [[vancomycin]] because these organisms are no longer susceptibile to vancomycin. However, to date, all VISA and VRSA isolates have been susceptible to other Food and Drug Administration (FDA) approved drugs like [[trimethoprim]]/[[sulfamethoxazole]], [[clindamycin]], or ceftaroline. | ||
==References== | ==References== | ||
Revision as of 15:51, 17 December 2012
|
Vancomycin-resistant Staphylococcus aureus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant Staphylococcus aureus medical therapy On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus medical therapy |
|
FDA on Vancomycin-resistant Staphylococcus aureus medical therapy |
|
CDC on Vancomycin-resistant Staphylococcus aureus medical therapy |
|
Vancomycin-resistant Staphylococcus aureus medical therapy in the news |
|
Blogs on Vancomycin-resistant Staphylococcus aureus medical therapy |
|
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
|
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
VISA and VRSA cannot be successfully treated with vancomycin because these organisms are no longer susceptibile to vancomycin. However, to date, all VISA and VRSA isolates have been susceptible to other Food and Drug Administration (FDA) approved drugs like trimethoprim/sulfamethoxazole, clindamycin, or ceftaroline.